Why It Matters
Louisiana is moving toward legislation that would expand prostate cancer screening coverage for men beginning at age 40, a threshold five years earlier than the current standard. Senate Bill 84 would require health insurance plans to cover these screenings with no out-of-pocket costs to patients, addressing a public health challenge in a state with the second-highest prostate cancer incidence rate in the nation. The policy shift reflects growing recognition that early detection dramatically improves survival outcomes and could reduce long-term treatment costs for insurers and the healthcare system.
What Happened
The Louisiana Senate unanimously approved Senate Bill 84 on Tuesday, March 18, 2026, advancing the prostate cancer screening legislation to the state House of Representatives. The bill, sponsored by Sen. Brach Myers, R-Lafayette, received bipartisan support and backing from the American Cancer Society, a national advocacy organization focused on cancer prevention and treatment.
The legislation requires health insurance plans operating in Louisiana to cover prostate cancer screenings for men beginning at age 40, moving the standard screening age down from 50. Critically, the bill mandates that insurance companies cover these screenings at no cost to patients—eliminating copayments, deductibles, and other out-of-pocket expenses that may discourage individuals from seeking screening.
During Senate Insurance Committee proceedings, Myers emphasized the life-or-death implications of early detection. He highlighted that localized prostate cancer carries a 100 percent survival rate when caught early, but when the disease spreads to other body parts, the survival rate plummets to 38 percent. Alice Kline, representing the Louisiana chapter of the American Cancer Society, noted that even minor financial barriers can prevent people from scheduling cancer screenings, making zero-cost access essential to improving screening rates.
According to Myers, no health insurance companies registered opposition to the bill during the legislative process, suggesting broad industry alignment on the cost-benefit calculation. Myers stated that the measure should ultimately save insurance companies money by catching cancer at earlier, more treatable stages.
By The Numbers
- 147 per 100,000: The prostate cancer diagnosis rate among men in Louisiana, based on Louisiana Cancer Research Center calculations, ranking the state second nationally
- 100% survival rate: Five-year survival rate for localized prostate cancer when detected early
- 38% survival rate: Five-year survival rate when prostate cancer has metastasized to other body parts
- $150: Approximate cost of a prostate cancer screening
- $40,000–$50,000 per year: Average annual treatment costs for prostate cancer
- 37-0: Senate vote margin in favor of SB 84, reflecting unanimous passage
Zoom Out
Louisiana’s prostate cancer screening expansion aligns with broader national conversations about cancer prevention and early detection. The American Cancer Society has advocated for earlier screening protocols across multiple cancer types as evidence increasingly shows that early intervention saves lives and reduces systemic healthcare costs.
Louisiana already mandates insurance coverage with no out-of-pocket costs for cervical and breast cancer screenings, establishing a precedent for gender-specific cancer screening mandates in state law. The prostate cancer bill follows this established pattern, extending the same protective framework to men’s health.
The bill reflects a nationwide trend toward removing financial barriers to preventive care. Multiple states have considered or enacted similar legislation requiring coverage of screenings at no patient cost, recognizing that financial deterrents disproportionately affect lower-income populations who have fewer resources to absorb screening expenses.
Cancer ranks as the second leading cause of death among men in Louisiana, behind heart disease, according to the U.S. Centers for Disease Control and Prevention. Prostate cancer represents a significant portion of this mortality burden, particularly in states with elevated incidence rates like Louisiana.
What’s Next
Senate Bill 84 now moves to the Louisiana House of Representatives for consideration. The bill would take effect beginning January 1, 2027, allowing insurers and healthcare providers time to adjust coverage policies and administrative systems to comply with the new requirements.
The House committee process will determine whether amendments occur or if the bill advances to a floor vote in its current form. Given the Senate’s unanimous passage and reported absence of industry opposition, House action is expected to proceed without significant delays, though timing remains subject to legislative schedule and procedural requirements.